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Available online xxxxIn the light of conﬂicting reports on the ability of copper(II) complexes of amyloid beta (Aβ) peptides to form ter-
nary complexes with small molecules co-present in the biological milieu, we performed a study of coordination
equilibria in the system containing Cu(II) ions, the Aβ1–16 peptide, glutamic acid and 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid, HEPES) buffer. Using
potentiometry, isothermal titration calorimetry (ITC), UV–visible spectroscopy and EPR, we concluded that
glutamic acid was not able to form such a ternary complex, but can efﬁciently compete for the Cu(II) ion with
the Aβ peptide at Glu concentrations relevant for the synaptic cleft. We also found that the literature constants
for Cu(II) complexes with Glu were overestimated, but this effect was partially compensated by the formation
of a ternary Cu(Glu)(HEPES) complex. Our results indicate that small molecules co-present with Cu(II) ions
and Aβ peptides in the synaptic cleft are not very likely to enhance Cu(II)/Aβ interactions, but instead should
be considered as a Cu(II) buffering system that may help prevent these interactions and participate in Cu(II)
clearance from the synaptic cleft.
© 2016 Elsevier Inc. All rights reserved.Keywords:
Cu(II)-Aβ complexes
glutamic acid
ternary complexes1. Introduction
The Cu(II) interactions with Aβ peptides, predominantly Aβ1–42 and
Aβ1–40, have been implicated in the etiology of Alzheimer's Disease
(AD) [1–4]. Major lines of evidence described in the literature include
association of Cu(II) ions with amyloid plaques composed of Aβ
peptides isolated from post-mortem AD brains, enhancement of Aβ ag-
gregation by Cu(II) ions, and support of Cu(II)/Cu(I) redox cycling by
the Aβ peptides, yielding deleterious reactive oxygen species. Mono-
meric Aβ peptides bind one Cu(II) ion with a conditional stability
constant at pH 7.4 (CK7.4) of 1010 M−1, and another at least 100 times
weaker [5,6]. These relatively low stability constants, determined for
both the short model peptide Aβ1–16, as well as the physiologically
relevant Aβ1–40 species, may be considered to weaken the proposal
associating the Aβ neurotoxicity with Cu(II) binding, because of the
presence of stronger Cu(II) ligands in the brain. Human serum albumin
(HSA), which binds one Cu(II) ion with CK7.4 of 1012 M−1 [7], is abun-
dant in the cerebrospinal ﬂuid at a micromolar level [8]. Thus, a higherFRHDSGYEVHHQK-amide; AD,
olecule; CK7.4, conditional afﬁn-
razineethanesulfonic acid or 2-
d; ITC, Isothermal Titration
lecule; PBT2, 5,7-dichloro-2-
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g. Biochem. (2016), http://dxconditional stability constant for Cu(II) binding, compared with Aβ1-x
peptides, co-localization with these peptides, and a high abundance of
HSA suggest that this protein could effectively compete for Cu(II) with
Aβ1-x peptides. Indeed, this protein was shown to withdraw Cu(II)
from Aβ1-x peptides directly and quickly, and was suggested by several
research groups, including us, to be a “brain guardian” preventing Aβ-
associated copper toxicity [9–12]. Recently, we combined our experi-
mental results with previous analytical reports to show that another
Aβ species, namely Aβ4-x (x = 16 is the model peptide, x = 42 is a
dominant brain species) binds one Cu(II) ion with CK7.4 of
3.4 × 1013 M−1, and withdraws Cu(II) from the Aβ1-x species quantita-
tively within the time required for sample mixing [13]. Taking into
account numerous reports that Aβ4-x species are at least as abundant
as the Aβ1-x species in both healthy and AD brains [14–17], and that
the main Cu(II) complex of the Aβ4-x peptide is redox inactive, one
can wonder whether the Cu(II)-mediated Aβ toxicity may ever occur
in vivo.
One way of resolving this dilemma is by considering that the
aggregated Aβ1-x peptides could bind Cu(II)more strongly than themo-
nomeric peptide. This idea was tested experimentally by two research
groups, but conﬂicting results were obtained (i.e. no enhancement vs.
a signiﬁcant and progressive enhancement) [18,19]. However, the
highest enhancement of binding reported [19] still would not overcome
the afﬁnity characteristic of the Aβ4-x peptides [13].
The formation of ternary complexes could be another way of
enhancing Cu(II) binding to Aβ1-x peptides. The susceptibility of modelptides to form ternary complexes: Neurotransmitter glutamate is a
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and common buffers was postulated in our early paper [20]. Further re-
search did not yield evidence for such abilities of HEPES buffer, but a re-
cent report indicated the formation of a ternary Tris complex (although
the reactionwas studied only at pH4.0) [21]. In our recent paperwedem-
onstrated that Aβ1–16 was able to form a ternary Cu(II) complex with 2-
[(dimethylamino)methyl]-8-hydroxyquinoline, an analog of the experi-
mental drug PBT2 (5,7-dichloro-2-[(dimethylamino)methyl]quinolin-8-
ol) which was designed to compete Cu(II) from the Aβ complex
[22]. Consideration of the most sui candidates for a ternary ligand
in vivo led us to propose glutamic acid (Glu), since AD pathology
initially affects glutamatergic synapses and the concentrations of
Glu in these synapses during neurotransmission may exceed
1 mM [23]. We therefore sought to identify ternary complexes in
the Cu(II)/Aβ1–16/Glu system.
2. Experimental
2.1. Potentiometry
Potentiometric titrations of the Cu(II)/Glu and Cu(II)/Glu/HEPES
systems were performed on a Titrando 907 automatic titrator
(Metrohm), using a combined glass-Ag/AgCl electrode (InLab®Micro,
Mettler Toledo, Switzerland), which was calibrated daily by nitric acid
titrations [24]. 0.1 M NaOH (carbon dioxide free) was used as titrant.
Sample volumes of 1.0–1.5 mL were used. For the binary Cu(II)/Glu
system the samples contained 0.5–1.0 mM Glu free acid, dissolved in
4 mM HNO3/96 mM KNO3. The Cu(II) complex formation was studied
for 1:2, 1:2.5, and 1:3 metal-to-ligand stoichiometries, using Cu(II)
added as Cu(NO3)2. For the ternary system, the following sets of
millimolar Cu(II)/Glu/HEPES concentrations were used: 1/2/2, 1/1/4
and 0.5/1/4. All experiments were performed under argon at 25 °C,
in the pH range 2.3 to 12.2. The collected data were analyzed using
the SUPERQUAD and HYPERQUAD programs [25,26]. Three to ﬁve
titrations were included simultaneously into calculations, separately
for Glu andHEPES protonation, binary Cu(II) complexes and the ternary
system.
2.2. UV–visible (UV–vis) spectroscopy
UV–vis spectroscopy was used to characterize the formation of
Cu(II) complexes with Glu, HEPES, and Aβ1–16 (synthesized according
to the Fmoc strategy and puriﬁed in our laboratory as described [13]).
The UV–vis spectra were recorded at 25 °C on a LAMBDA 950 UV/vis/
NIR spectrophotometer (PerkinElmer), over the spectral range of 250–
850 nm. The optical path for all experiments was 1 cm. The concentra-
tion of Aβ1–16 was determined using an extinction coefﬁcient of
1400 M−1 cm−1 at 275 nm [13].
In acid/base titrations of Cu(II)/Glu and Cu(II)/Glu/HEPES systems,
0.5 mM Cu(II), 0.45:1 Cu(II)-to-Glu molar ratio, and 0.45:1:1 Cu(II)-
to-Glu-to-HEPES molar ratio were used. The samples were titrated
with NaOH by careful manual additions of very small amounts of the
concentrated base solution, in the pH range of 2.9–11.0.
In separate experiments Cu(II)/Aβ1–16 (0.9:1 ratio) or Cu(II)/Glu
(0.9:1 ratio) in 50 mM HEPES (pH 7.4) was titrated with 40 mM Glu
in the same buffer, to the ﬁnal excess of Glu over Cu(II) of 77 for each
sample. The initial concentrations of Cu(II) were equal to 0.5 mM.
2.3. Isothermal titration calorimetry (ITC)
Calorimetric titrations were carried out on the Nano ITC Standard
Volume calorimeter (TA Instruments). The sample cell (950 μL) was
ﬁlled with a Cu(II) and Aβ1–16 solution (with metal to peptide ratio of
0.9:1) in 50mMHEPES buffer at pH 7.4. Concentrations of the resulting
Cu(II)/Aβ1–16 complexwerewithin the range of 48–600 μM. The syringe
(250 μL) was loaded with 10 mM Glu in 50 mM HEPES at pH 7.4.Please cite this article as: T. Frączyk, et al., On the ability of CuAβ1-x pe
competitor while not a ternary part..., J. Inorg. Biochem. (2016), http://dxTypically, 8 μL of the Glu solution was added to the Cu(II)/Aβ1–16 com-
plex solution at 1000 s intervals using a stirring speed of 200 rpm. The
measurements were performed at 25 °C.2.4. EPR spectroscopy
Samples containing Cu(II)/Aβ1–16/Glu in the ratio 1:1:n (n=0–100)
were prepared in 20 mM HEPES pH 6.9. Copper was added from a
10 mM 65CuCl2 stock to a ﬁnal concentration of 200 μM, with 10% v/v
glycerol was included as a cryoprotectant as described previously [22,
27]. Reference spectra corresponding to CuAβ1–16 and CuGlu2 were
obtained using Cu(II)/Aβ1–16 0.9:1 and Cu(II)/Glu 1:50 mixtures,
respectively.
X-band (9.45 GHz) continuous-wave EPR spectra were obtained at
77 K using a Bruker Elexsys E500 spectrometer ﬁtted with a Bruker
super-high-Q probehead (ER 4122SHQE) and a quartz cold ﬁnger insert
(Wilmad, WG-816-B-Q). The following experimental settings were
used: microwave frequency, 9.45 GHz; microwave power, 10 mW;
magnetic ﬁeld modulation amplitude, 5 G; ﬁeld modulation frequency,
100 kHz; receiver time constant, 164 ms; receiver gain, 56 dB; sweep
rate, 6.67 gauss s−1. Baseline correction was performed by subtraction
of a spectrum of buffer only.
To deconvolute the Cu(II)/Aβ1–16/Glu 1:1:n spectra, all of the
experimental ﬁrst-harmonic spectra were ﬁrst normalized by double-
integration. A reconstruction of the Cu(II)/Aβ1–16/Glu 1:1:n spectra
was then made by weighted addition of normalized CuAβ1–16 and
Cu(Glu)2 spectra, with the weightings adjusted in order to minimize
the mean-squared deviation between the reconstruction and the Cu/
Aβ1–16/Glu 1:1:n spectrum. The speciation of the CuGlu spectral compo-
nentwas atmost only a few percent for all conditions andwas therefore
not explicitly included in the ﬁts.2.5. Computational methods
Calculations were performed with the use of a custom-made soft-
ware implemented in the Wolfram Mathematica 9 environment,
which serves the purpose of determination of binding constants in an
investigated system, along with the deconvolution of spectroscopic
data in the course of the ﬁtting procedure.
The binding constants for Cu(II)/Glu and Cu(II)/Glu/HEPES systems
were obtained from potentiometric experiments. The species concen-
tration curves were calculated from these binding constants and
deconvolution of the spectra was performed by the linear least square
ﬁtting to the aforementioned curves. The UV–vis spectra of CuHL+,
CuL and CuL22− complex species (L denotes fully deprotonated glutamic
acid molecule) were obtained by global deconvolution of acid/base
titrations and Glu titrations of the Cu(II)/HEPES samples. The spec-
trum of the CuLB− complex (B denotes fully deprotonated HEPES
buffer molecule) was obtained from the deconvolution of pH titra-
tion spectra in the presence of HEPES, with all other spectra ﬁxed.
Subsequently, the results of the deconvolution were applied to the
experiment in which the Cu(II)/Aβ1–16 samples were titrated with
Glu. The full set of UV–vis spectra was fully explained by the compe-
tition model where the Cu(II) ion was largely transferred from the
CuAβ1–16 complex to the CuL22− complexes. To account for the dilu-
tion of sample constituents, actual total concentrations of Cu(II),
Aβ1–16, Glu, and HEPES were considered in calculations for every cor-
responding raw spectrum.
In the calorimetric experiments satisfactory ﬁts were obtained for
the competition reaction model where Cu(II) ions were extracted
from the CuAβ1–16 complex to CuL and subsequently CuL22− complexes,
with traces of the CuLB− complex. The assumption of amodel including
the formation of a ternary CuAβ1–16 L complex had no signiﬁcant impact
on the quality of the ﬁts.ptides to form ternary complexes: Neurotransmitter glutamate is a
.doi.org/10.1016/j.jinorgbio.2016.02.035
Fig. 1. UV–vis spectra of Cu(II) complexes with Glu (A) and with Glu/HEPES (B) at
different pH values. The spectra were recorded at 25 °C for samples containing 0.5 mM
Cu(NO3)2 and 1.2 mM Glu or/and 1.2 mM HEPES.
3T. Frączyk et al. / Journal of Inorganic Biochemistry xxx (2016) xxx–xxx3. Results
3.1. Preliminary studies
Our initial strategy of determination of coordination equilibria in the
Cu(II)/Aβ1–16/Glu system was based on three independent experimen-
tal methods. ITC titrations of equimolar Cu(II)/Aβ1–16 samples with a
glutamic acid solution were followed by deconvolution of titration
curves with the afﬁnity constants of both component binary systems
(Cu(II)/Aβ1–16 and Cu(II)/Glu) taken from previous studies. UV–vis
studies were aimed at providing independent support for these
deconvolutions, and EPR experiments were anticipated to provide us
with parameters of the ternary complex(es) that would help us in
deciphering its(their) structure.
The ITC experiments were performed in a 50 mM HEPES buffer at
pH 7.4. We used the CK7.4 value for the CuAβ1–16 complex, established
by spectroscopic titrations and the full set of logarithmic values of
cumulative stability constants (log β) for the Cu(II)/Glu system present-
ed in the literature [5]. The calculations performed using only the binary
systems indicated a need to include additional species, whichwe initial-
ly interpreted as evidence for a ternary complex. Theﬁtswere, however,
unsatisfactory (Fig. S1). We did not include HEPES in our initial consid-
erations, because it would not interact with the Cu(II)/Aβ1–16 system
under these experimental conditions [5,28], but then we realized that
HEPES, present at a high molar excess over Cu(II) and Glu might
interfere with the Cu(II)/Glu system, by forming a ternary complex
[29]. Therefore we decided to re-evaluate the Cu(II)/Glu/HEPES system
by potentiometry and UV–vis spectroscopy and reanalyze the ITC
results using the newly established stability constants.
3.2. Potentiometric and UV–vis studies of the Cu(II)/Glu/HEPES system
These experiments started with the potentiometric and UV–vis
studies of the Cu(II)/Glu system. The stability constants obtained by
potentiometry are presented in Table 1. The potentiometric results
were validated by spectrophotometric pH titrations.
Examples of UV–vis acid/base titrations are shown in Fig. 1. In
addition, we performed spectrophotometric titrations of Cu(II)/Glu
(0.9:1) with Glu in 50 mM HEPES at pH 7.4. The spectra from all titra-
tions were pooled together in calculations, and deconvoluted according
to the coordination model using the stability constants presented in
Table 1. The spectral parameters obtained are presented in Table 2.Table 1
Protonation constants and stability constants of Cu(II) complexes (log β values) of
glutamic acid (L) and HEPES (B) at I = 0.1 M (KNO3) and 25 °C.
Species log β (this work)a log β (reference study)b
Glutamic acid
H3L+ 15.92(2) 16.27
H2L 13.811(9) 13.99
HL− 9.603(6) 9.746
CuHL+ 12.82(2) 12.73
CuL 8.24(1) 8.545
CuH2L2 n.d.c 25.18
CuHL2− n.d. 20.57
CuL22− 14.32(2) 15.22
HEPES
H2B+ 10.53(1) 10.397
HB 7.377(4) 7.409
CuB+ 3.22d 3.22
Ternary
CuLB− 10.71(7) n.d.
a Standard deviations on the least signiﬁcant digits, provided by HYPERQUAD [24], are
given in parentheses.
b Ref. [30] for Glu, ref. [28] for HEPES.
c n.d.; not detected.
d value not ﬁtted, but found to be correct in the course of potentiometric calculations.
Please cite this article as: T. Frączyk, et al., On the ability of CuAβ1-x pe
competitor while not a ternary part..., J. Inorg. Biochem. (2016), http://dxThe deconvolution conﬁrmed the presence of the ternary complex
formed by Cu(II) with Glu and HEPES, with a CuLB− stoichiometry
(Figs. 2, S2-S4).
3.3. UV–vis and EPR studies of the Cu(II)/Aβ1–16/Glu/HEPES system
The next step was to perform UV–vis monitored titrations of the
Cu(II)/Aβ1–16 system in HEPES at pH 7.4 with a concentrated (40 mM)
Glu solution. These experiments allowed us to test theworking hypoth-
esis assuming the presence of ternary Cu(II)/Aβ1–16/Glu complexes. The
modelwithout a ternary complex fully explained changes of absorbance
during titrations. The values of absorbance for selected wavelengths
along with the best ﬁt to the ﬁnal coordination model are presented in
Fig. 3. In line with the UV–vis observations, changes in the EPR spectra
during titration of Glu into 1:1 Cu(II)/Aβ1–16 could be accounted for by
the presence of only binary CuAβ1–16 and CuGlu2 complexes (Fig. 4).
3.4. ITC studies of the Cu(II)/Aβ1–16/Glu/HEPES system
We also performed ITC experiments analogous to UV–vis titrations.
First, from a titration of Aβ1–16 in HEPES at pH 7.4 with an aqueous
Cu(II) solution we determined the ΔH value for Aβ1–16 (−34.7 ±
1.6 kJ/mol), which we applied in the calculations of parameters of the
four-component system where the Glu solution in HEPES was titrated
to Cu(II)/Aβ1–16 samples in HEPES. Control experiments showed that
Glu did not interact with HEPES and Aβ1–16 in the absence of Cu(II)
ions (Fig. S6 in the Supplementary Information ﬁle). For the Cu(II)/
Aβ1–16/Glu/HEPES system we used a range of concentrations of Cu(II)/
Aβ1–16 samples from 0.048 to 0.600mM, butmaintained the concentra-
tions of HEPES and added (syringe) Glu constant at 50 and 10 mM,
respectively. Thus, the results were obtained for a range of ratios of
HEPES and Glu to other reagents. This allowed us to test the existence
of all potential ternary complexes. The global ﬁt of the model assuming
the following complexes: CuAβ1–16, CuL, CuL22− and CuLB− is shown in
Fig. 5. After taking into consideration the existence of CuLB− we
obtained a better ﬁt than the one mentioned in the Section 3.1. TheTable 2
Parameters of deconvolutedUV–vis spectra (the least squareﬁtting parameterswere χ2=
2.42 × 10−5 and R2 = 0.999994).
Species λmax (nm) ε (M−1 cm−1)
CuHL+ 734 41
CuL 706 47
CuL22− 617 72
CuLB− 643 48
ptides to form ternary complexes: Neurotransmitter glutamate is a
.doi.org/10.1016/j.jinorgbio.2016.02.035
Fig. 2. The spectra of Cu(II) complexes with glutamic acid and HEPES, calculated on the
basis of potentiometric data shown in Table 1, and UV–vis titration data. L denotes Glu,
B denotes HEPES.
Fig. 4. X-band (9.45 GHz) EPR spectra (77 K) monitoring of the titration of Glu into a
solution containing 0.2 mM Cu/Aβ1–16 1:1 in HEPES pH 6.9 with 10% v/v glycerol.
Dashed vertical lines show resolved hyperﬁne lines corresponding to A||(65Cu) for
CuAβ1–16 and CuGlu2. The speciation curves (inset) were obtained by deconvolution of
the spectra (shown in Fig. S5 in the Supplementary Information ﬁle).
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Information ﬁle. The addition of hypothetical ternary complexes
(other than CuLB−) containing Cu(II), Aβ1–16 and Glu did not improve
the ﬁt, because the predicted amounts of such complexes were far
below the error of the estimate. This result was also consistent with
UV–vis and EPR results.
4. Discussion
4.1. Ternary Cu(II) complexes of Aβ1–16
Using potentiometry, ITC, UV–vis and EPR we obtained a compre-
hensive description of Cu(II) coordination equilibria in the presence of
Aβ1–16, Glu and HEPES. Contrary to our initial expectations, we proved
the absence of ternary Cu(II) complexes with Aβ1–16 and Glu. This
ﬁnding has important consequences. Previously we determined the
structure of a ternary complex formed by Cu(II) ion with Aβ1–16
and 2-[(dimethylamino)methyl]-8-hydroxyquinoline [22]. In that com-
plex the main chelating agent was the terdentate quinoline, and theFig. 3. Absorbance values in the Cu(II)/Aβ1–16/Glu/HEPES system in a function of a molar
ratio of Glu to Cu(II). A Glu solution (40 mM) in 50 mM HEPES (pH 7.4) was added to
Cu(II)/Aβ1–16 in 50 mM HEPES (pH 7.4). The best ﬁt for the coordination model
considering the presence of Cu(II)/Aβ1–16, Cu(II)/HEPES, Cu(II)/Glu/HEPES, Cu(II)/Glu,
and Cu(II)/Glu2 is represented by solid lines, at various wavelengths. The following
wavelength values were selected for illustration of whole spectra ﬁts: 617 nm (λmax for
CuL2), 706 nm (λmax for CuL), and 750 nm (chosen as a wavelength at which all
complex species present in the equilibrium absorb signiﬁcantly).
Please cite this article as: T. Frączyk, et al., On the ability of CuAβ1-x pe
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His residue. These two facts suggest a general rule, according to which
Aβ1–16, and more generally, Aβ1-x peptides, form ternary complexes
preferentially by providing auxiliary His ligands to complete the coordi-
nation sphere of the Cu(II) ion pre-formed by terdentate chelating
ligands. This in turn is possible when the stability constant of the binary
complex with the terdentate ligand is higher than that of the CuAβ1-x
complex. Glutamic acid, and generally amino acids except perhaps His,
do not meet this criterion. Incidentally, this ﬁnding provides an
additional argument for the validity of the method of determination of
binding constants of Cu(II) complexes with Aβ peptides based on Gly
as competitive ligand [5].4.2. Re-evaluated stability constants for the Cu(II)/Glu system and Cu(II)
binding in the synaptic cleft
The full characterization of the Cu(II)/Aβ1–16/Glu system in terms of
stability constants empowered us to investigate the potential impact of
the neurotransmitter (Glu) on the likelihood of formation of Cu(II)
complexes of Aβ1-x peptides in the synaptic cleft, the most probable
localization of neurotoxic reactivity of these Aβ1-x peptides [1]. We
calculated the distribution of Cu(II) ions between Aβ1–16 and Glu for
several concentrations of reagents possibly relevant for the conditions
in the synaptic cleft (Fig. 6). Glu is a neurotransmitter, with peak
concentrations higher than 1 mM shortly after its release from the pre-
synaptic neuron, but falling to low micromolar values prior to the next
burst [23]. To simplify thesemodel calculations, we ﬁxedGlu concentra-
tion at 2mM, to represent this burst.We set Cu(II) andAβ to be equimo-
lar and varied their concentrations between 1 μM and 300 μM. The
lower limit corresponds to just a few atoms/molecules in the synaptic
cleft, the upper one is similar to the highest Cu(II) concentration
observed during neurotransmission [31,32], and the average concentra-
tion of Cu(II) in the synaptic cleft, derived from measurements done in
synaptosomes, of 14 μM, is within this range [33]. Interestingly, our
calculations show that Glu could signiﬁcantly reduce the amount of
Aβ bound Cu(II) ions, especially at a low abundance of CuAβ. Therefore,
Glu and similar small molecules could have an additional function in
clearing Cu(II) ions from the synaptic cleft, and thus preventing the for-
mation of deleterious CuAβ1-x complexes. Notably, under the conditions
of our calculations the abundance of Glu bound Cu(II) ions never
exceeded 1% of the total neurotransmitter, and thus this hypothetical
interaction would not likely interfere with neurotransmission.ptides to form ternary complexes: Neurotransmitter glutamate is a
.doi.org/10.1016/j.jinorgbio.2016.02.035
Fig. 5. ITC titrations of Cu(II)/Aβ1–16 (0.9/1) in 50mMHEPES at pH7.4 and 25 °C. The initial concentrations of Cu(II)were 0.048 (A), 0.100 (B), 0.311 (C), 0.421 (D) 0.466 (E), and 0.600mM
(F). The upper plots show raw data from the experiments; the lower plots show the heat in each injection (open dots) after subtraction of heat of Glu dilution (data from Fig. S6) in a
function of molar ratio of Glu to Cu(II), with the ﬁtting of the model assuming the presence of the following set of species: Cu(II)/Aβ1–16, Cu(II)/HEPES, Cu(II)/Glu/HEPES, Cu(II)/Glu,
and Cu(II)/Glu2. Values of log β were derived from ref. [5] for Cu(II)/Aβ1–16, ref. [28] for Cu(II)/HEPES, and from potentiometric experiments (this paper) for all other complexes.
Fig. 6. Cu(II) species distribution simulated for a range of equimolar concentrations of
Cu(II) and Aβ (from 1 to 300 μM) and 2 mM Glu at pH 7.4.
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Our study provided three signiﬁcant results. The nonexistence of
ternary complexes with Glu (and, more broadly, with amino acids) in
a system containing equimolar Cu(II) and Aβ provides a signiﬁcant
benchmark for studies of chemistry of these complexes. A tentative
rule on formation of such ternary complexes will assist studies on
Cu(II) chelating agents as potential AD drugs. Finally, our quantitative
results indicate that Glu released in the process of neurotransmission
may be part of the synaptic clearance system for Cu(II) ions preventing
the formation of neurotoxic complexes of Aβ peptides.
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